Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Up - What's Next?

Key Points

• Stock gapped up: Shares opened at $59.69 after a $56.89 close and last traded near $58.38 on light volume, reflecting about a 2.0% intraday move.
• Earnings miss: Novozymes reported Q EPS of $0.35 versus $0.79 expected and revenue of $1.18B versus $1.22B consensus, with analysts forecasting FY EPS of about $1.82.
• Valuation and business: The company has a $24.07B market cap, P/E of 41.47 and PEG of 1.02, and sells industrial enzymes and microbial solutions for household care, food & beverage, bioenergy, agriculture and industrial processing.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s stock price gapped up prior to trading on Thursday . The stock had previously closed at $56.89, but opened at $59.69. Novozymes A/S shares last traded at $58.38, with a volume of 9,414 shares trading hands.

Novozymes A/S Stock Up 2.0%

The company has a market cap of $24.07 billion, a price-to-earnings ratio of 41.47, a P/E/G ratio of 1.02 and a beta of 1.11. The stock's 50-day moving average is $59.60 and its 200-day moving average is $61.50. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing analysts' consensus estimates of $0.79 by ($0.44). Novozymes A/S had a return on equity of 6.38% and a net margin of 13.96%.The company had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.22 billion. On average, analysts anticipate that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company's product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.